Larry Michael Mertz - Aug 22, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Technology Officer
Signature: /s/ Steven Reichling, attorney-in-fact
Stock symbol: AXDX
Transactions as of: Aug 22, 2022
Transactions value $: $69,861
Form type: 4
Date filed: 8/22/2022, 03:30 PM
Previous filing: Jul 13, 2022
Next filing: Aug 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Purchase	$69.9K	+51.7K	+15.6%	$1.35	383K	Aug 22, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.